Blood cancer Clinical Trials in St Louis, MO

As of June 2026, 84 paid clinical trials are recruiting for Blood cancer in St Louis, Missouri. Blood cancer trials investigate CAR-T cell therapies, bispecific antibodies, BTK and BCL-2 inhibitors, and novel combinations across leukemias, lymphomas, myeloma, and myelodysplastic syndromes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 12, 2026.

Filter results

Filter results

State

City

Facility

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

84 clinical trials for Blood cancer

·Clear filters·↓ Download CSV

Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

for Relapsed or Refractory Acute Myeloid Leukemia (AML)

26 locations incl. Birmingham

Sponsor: Institut de Recherches Internationales Servier

Sex: All·Age: 18+

Code: NCT02074839·Phase 1·Recruiting

Apply to this trial

A Long-term Extension Study of PCI-32765 (Ibrutinib)

for Chronic Lymphocytic Leukemia

Drug: Ibrutinib

32 locations incl. Duarte

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT01804686·Phase 3·Recruiting

Apply to this trial

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

for Hematologic Malignancies

142 locations incl. Birmingham

Sponsor: Center for International Blood and Marrow Transplant Research

Sex: All·Age: All ages

Code: NCT01351545·Recruiting

Apply to this trial

Collection of Tissue Samples for Cancer Research

for Neoplasms

16 locations incl. Sacramento

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 2 Months+

Code: NCT00900198·Recruiting

Apply to this trial

Conditions in Blood cancer (St Louis, MO)

Multiple myeloma· 20 Acute myeloid leukemia (AML)· 19 Myelodysplastic syndromes (MDS)· 15 Non-Hodgkin lymphoma· 13 Hematologic malignancy· 10 Chronic lymphocytic leukemia (CLL)· 7 Leukemia (other)· 7 Diffuse large B-cell lymphoma (DLBCL)· 7 Mantle cell lymphoma· 7 Small lymphocytic lymphoma· 5 Acute lymphoblastic leukemia· 4 Myelofibrosis· 4 Follicular lymphoma· 4 Marginal zone lymphoma· 4 Myeloproliferative neoplasm· 2 Hodgkin lymphoma· 2